Liminatus Pharma, Inc. (LIMNW) operating KPIs

LIMNWNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31Also trades as LIMN

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 14, 2026Score 2/30

$0.04+0.00 (0.00%)

Close on Oct 30, 2026Market cap $189.39MP/E –Yield –

KPIs

Operating metrics that drive Liminatus Pharma's business

Coming soon

This tab will track the numbers specific to Liminatus Pharma's business model — such as store count, revenue by banner, revenue per store and new openings — taken from filings and earnings releases.